TRVI

Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in New Haven, Connecticut, dedicated to the development of innovative therapies for serious neurology-mediated conditions. Its lead product candidate, Haduvio, targets significant unmet medical needs and is currently undergoing clinical trials, underscoring the company's commitment to advancing its robust therapeutic pipeline. With a strong focus on drug development and strategic commercialization opportunities, Trevi Therapeutics is poised to make a transformative impact in the neurology sector, offering promising solutions for patients suffering from debilitating conditions.